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Background: The significance of a unique inhibitory Fc receptor for IgG, FcγRIIB (RIIB), in the prevention of spontaneous
production of autoantibodies remains controversial, due mainly to the fact that the RIIB locus is adjacent to the
autoimmune-related SLAM locus harboring the genes coding for signaling lymphocyte activation molecules, making it
difficult to isolate the effect of RIIB deletion from that of SLAM in gene-targeted mice. Our objective was to determine
the influence of RIIB deletion on the spontaneous development of autoimmune diseases and to compare it with that of
potentially pathogenic SLAM.
Results: We established two congenic C57BL/6 (B6) strains, one with the RIIB deletion and the other with SLAM, by
backcrossing 129/SvJ-based RIIB-deficient mice into the B6 genetic background extensively. The RIIB deficiency indeed
led to the production and/or accumulation of a small amount of anti-nuclear autoantibodies (ANAs) and to weak IgG
immune-complex deposition in glomeruli without any obvious manifestation of lupus nephritis. In contrast, pathogenic
SLAM in the B6 genetic background induced ANAs but no IgG immune-complex deposition in the kidneys. Naïve SLAM
mice but not RIIB-deficient mice exhibited hyperplasia of splenic germinal centers.
Conclusion: The present results clarify the roles of RIIB in preventing production and/or accumulation of a small amount
of ANAs, and development of glomerulonephritis. The combined effects of RIIB deletion and pathogenic SLAM can lead
to severe lupus nephritis in the B6 genetic background.
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Inhibitory receptorBackground
Systemic lupus erythematosus (SLE) is characterized by
spontaneous production of autoantibodies including
anti-nuclear autoantibodies (ANAs), and by development
of vasculitis and autoimmune glomerulonephritis (so-called
lupus nephritis) preferentially in females. The genetic
susceptibility loci have been mapped throughout the
chromosomes, the major locus having been mapped to
the chromosome 1 telomeric region, in which many* Correspondence: tostakai@idac.tohoku.ac.jp
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unless otherwise stated.immunoregulatory genes are concentrated in humans as
well as in mice [1-3]. One of the major susceptible haplo-
types in this region has been identified in murine SLE
models as the group of seven genes for the signal lympho-
cyte activation molecule (SLAM or CD2) family members,
which regulate cognate interactions between T and B cells,
and signaling [4]. Interestingly, while both SLAM haplo-
types 1 and 2 in non-autoimmune strains of mice, such as
C57BL/6 (B6) and 129/SvJ, respectively, are not harmful
when expressed in the original genetic backgrounds of the
host strains, SLAM haplotype 2 in 129 mice (SLAM129)
renders the hosts susceptible to autoimmunity, ANAs being
produced when expressed in the B6 genetic backgroundtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cluster, Cd48, Ly108, Cd84, and Cs1, vary in their
expression in splenic B and/or T cells between B6 mice
harboring haplotypes 1 and 2 [4]. In particular, Ly108 was
suggested to be one of the determinants of the autoimmun-
ity susceptibility [4,6].
Another important susceptible gene for autoimmunity in
this 1q telomeric region has been suggested to be the gene
coding for a unique inhibitory Fc receptor for IgG (FcγR),
FcγRIIB (RIIB) [7-11]. Generally, it is well established that
the FcγR family molecules expressed on myeloid-lineage
cells and B cells play crucial roles in adaptive immune
responses and inflammation, in which activating-type
FcγRs such as FcγRIII initiate and accelerate the responses,
while inhibitory RIIB decreases them upon co-engagement
with other activating-type FcγRs or B cell antigen receptors
via IgG immune complexes (IgG-ICs) [7,9-12]. Thus, RIIB
executes important IgG-mediated feedback regulation of
cell activation, proliferation and antibody/cytokine produc-
tion, as demonstrated in different experimental settings
using RIIB-deficient (RIIB−/−) mice [13-15]. In contrast to
this well-established feedback regulation, the roles of RIIB
in maintaining tolerance and in preventing spontaneous
development of autoimmunity, however, remain uncertain
due to the inconsistent phenotypes observed in RIIB−/−
mice by different research groups, particularly in terms of
the level of ANAs and the severity of lupus nephritis
[8,16-18]. In addition, a recent report [19] pointed out the
role of RIIB expressed in liver sinusoidal endothelial cells
in the clearance of small size IgG-ICs, so the additional
RIIB function of minimizing the level of pathologic IgG-
ICs in the blood should also be taken into account.
Importantly, the FcR locus is adjacent to the SLAM
locus in the 1q telomere of the mouse genome [1,4]. It
has been pointed out that special care should be taken
when examining the precise influence of any targeted
gene, such as that of RIIB, located in this region on the
occurrence of spontaneous autoantibody production and of
lupus nephritis, by eliminating any influence of SLAM
members in gene-targeted mice generated with 129-derived
ES cells and backcrossed into the genetic background of
B6 [1,4,5]. Therefore, the differences in the observed
phenotypes in RIIB−/− mice could be due, at least in part,
to the heterogeneity of the genomic interval around the
RIIB−/− locus in the B6 background, which might be co-
segregated with the autoimmune-prone SLAM129 haplo-
type discussed above [4,6]. In addition to the genetic
heterogeneity of RIIB−/− mice, unidentified differences in
environmental conditions such as those in nutrition and
the gut microbial flora should also be considered.
To clarify the role of RIIB in peripheral tolerance in the
absence of any effect of the pathogenic SLAM129 haplo-
type, we separated the RIIB−/− locus and the SLAM129
locus by extensively backcrossing our RIIB−/− mice intothe B6 background, followed by analysis of microsatellite
markers in this genetic interval in the offspring. Each of the
two congenic B6 strains obtained, one harboring RIIB−/−
and the other pathogenic SLAM129, exhibited unique phe-
notypes as to germinal center formation in the spleen,
ANAs in serum, IgG-IC deposition in the kidneys, and
development of lupus nephritis, which revealed the exact
roles of RIIB and SLAM129-derived set of molecules in




The original FcγRIIB (RIIB)-deficient mice constructed
with a 129 and B6 hybrid background [13] were back-
crossed into the B6 background for 12 generations as
described previously [16] using C57BL/6NCrj mice
(Charles River Inc. Japan, Kanagawa, Japan), and then,
in this study, they were further backcrossed up to the
28th generation (Additional file 1: Figure S1A). The
offspring were genotyped by analysis of simple se-
quence length polymorphisms (SSLP) using the seven-
teen SSLP markers on chromosome 1, which allow
discrimination of the polymorphisms in B6 and 129
mice, particularly around the Fcgr2b gene and for the
SLAM haplotype (Additional file 1: Figure S1). SSLP
analysis was conducted by the Central Institute of
Experimental Animals (Kawasaki, Japan). We estab-
lished two substrains, N22 and N28 B6.RIIB−/−SLAMB6
(RIIB−/−) and B6.RIIB+/+SLAM129 (SLAM129) mice as
well as N28 B6.RIIB−/−SLAM129 (RIIB−/−SLAM129) mice
as controls (Additional file 1: Figure S1). RIIB-deficient
mice were also provided by S. Hirose of Juntendo
Univ. (Tokyo), or purchased from TACONIC® Farms
(Germantown, NY, USA). When pertinent, we refer to
our N28 RIIB−/− mice used in the present study as
RIIB−/−SENDAI and those obtained or purchased from
others as RIIB−/−TOKYO or RIIB−/−TACONIC, re-
spectively, in order to distinguish the data in figures.
In several experiments, we also employed B6 mice ob-
tained from CLEA Japan, Inc. (Tokyo, Japan) as aged
controls or a 12-month-old NZB/W F1 female mouse
from Japan SLC, Inc. (Shizuoka, Japan) as an auto-
immune control. For adaptation, the B6 mice of non-
littermate controls and NZB/W F1, RIIB
−/−TOKYO,
and RIIB−/−TACONIC mice were housed in our facil-
ity for at least 6 months before use. All mice were
housed in the Experimental Animal Facility of The
Institute of Development, Aging and Cancer (Tohoku
University, Sendai, Japan), an environmentally con-
trolled and specific pathogen-free facility. All animal
protocols were reviewed and approved by the Animal
Studies Committee of the Tohoku University, and we
followed the guidelines defined by the committee.
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For isolation of genomic DNA samples, tail tips from mice
were lysed by incubation in 100 μl of tail lysis buffer
[50 mM Tris-HCl (pH8.0), 20 mM NaCl, 1 mM EDTA,
0.063% SDS and 1 mg/ml proteinase K] for at least 4 hours
at 55°C. Tail lysates were diluted with 10 volumes of water,
and then subjected to PCR amplification using gene-
specific PCR primer pairs (Additional file 1: Table S1) and
KOD FX polymerase (TOYOBO Co. Ltd., Osaka, Japan)
as follows: initial 2-min incubation at 94°C, 30 cycles
consisting of 95°C for 30 s, 60°C for 30 s and 72°C for
90 s, and a final 10 min elongation step at 72°C. For deter-
mination of SNPs in the vicinity of the Fcgr2b locus, PCR
products were directly sequenced using specific primers
(Additional file 1: Table S1) with a 3130x1 Sequencer (Life
Technologies, Waltham, MA, USA).
Antibodies
For FACS analysis, the following fluorochrome-labeled
antibodies specific for mouse molecules were used:
CD4-FITC, CD4-Alexa647, CD19-Pacific blue (BioLe-
gend, Inc., San Diego, CA, USA), and GL7-FITC and
FAS-PE (Becton Dickinson Ltd., Franklin Lakes, NJ,
USA). For immunohistochemistry, anti-mouse-IgM-
Alexa488, anti-rat-IgG-Alexa488, and anti-mouse-IgG-
Alexa555 (Invitrogen Life Technologies, Carlsbad, CA,
USA), anti-mouse-IgD-biotin (BioLegend), GL7-Alexa488
(eBiosciences Inc., San Diego, CA, USA), and anti-mouse
IgM F(ab’)2 Alexa647 (Jackson ImmunoResearch labora-
tories Inc., West grove, PA, USA) were used.
Histological study and immunohistochemistry
Kidneys were fixed with 4% paraformaldehyde in phos-
phate buffer. Specimens were embedded in paraffin, sec-
tioned at 2 μm, and then stained with hematoxylin and
eosin (HE) or periodic acid-Schiff (PAS). To evaluate
glomerular lesions, at least 25 glomeruli were examined
per HE-stained section by light microscopy based on
pathological manifestations of inflammation, and/or tissue
damage in a blind manner [20]. The severity of glomerulo-
nephritis was estimated as follows; grade 0, normal; grade
1, neutrophil infiltration and segmental mesangial prolifer-
ation; grade 2, limited lobulated glomeruli in grade 1; and
grade 3, crescent formation and severe lobulated glom-
eruli with lymphocyte infiltration (Additional file 1: Figure
S2). To assay IgG-ICs deposition, kidney samples were
embedded in O.C.T. compound (Tissue-Tek, Miles, Inc.,
Elkhart, IN), snap-frozen in liquid nitrogen, and then
sectioned at 5 μm. The sections were fixed with 4% parafor-
maldehyde for 20 min, washed again three times with PBS,
and then preincubated for 1 hour at room temperature
with PBS containing 20% BSA to block nonspecific anti-
body binding. They were then incubated overnight at room
temperature with affinity-purified Alexa488-conjugatedgoat F(ab’)2 fragments (H + L chain) anti-mouse IgG
(Invitrogen). After washing three times with PBS, slides
were mounted and examined under an Olympus BX50
microscope equipped with an Olympus BH2-RFL-T3 mer-
cury lamp and appropriate optics.
Spleens were embedded in O.C.T. compound, frozen
in liquid nitrogen, and then sectioned at 8 μm. Sections
were fixed with acetone for 20 min at −20°C and then
air-dried for 1 hour. After washing with PBS six times, sec-
tions were pre-incubated for 1 hour at room temperature
with PBS containing 2% BSA for blocking, and then incu-
bated with Alexa488-labeled anti-mouse IgM (Invitrogen)
or Alexa488-labeled GL7, and biotinylated anti-mouse IgD
(eBiosciences) for staining of splenic B cells. After wash-
ing with PBS three times, sections were incubated with
1:2000 diluted Alexa546-conjugated streptavidin at 4°C
for 30 min.
Determination of ANA levels in sera from indirect
immunofluorescence and by HEp2 cell staining combined
with ELISA
For determination of gross ANA levels, serum samples
from 24–48-wk-old mice were serially diluted from 1:40
to 1:320 with PBS containing 1% BSA. HEp-2 cell-seeded
slides (Fluoro HEPANA test; MBL, Nagoya, Japan) were
incubated with diluted serum samples for 45 min at room
temperature, followed by brief washing and incubation
with PBS for 60 min. Anti-nuclear antibodies (ANA) were
detected with Alexa488-labeled anti-mouse IgG F(ab’)2
(Invitrogen Life Technologies) and visualized under a
fluorescence microscope (Olympus, Tokyo, Japan). To
determine ANA levels and the IgG isotypes by ELISA, sera
from mice were diluted 1:100 with PBS containing 1%
BSA and then added to a HEp-2 coated 96-well plate
(ANA HEp Screen ELISA kit; Abnova, Taipei, Taiwan). ANA
and the IgG isotypes were detected with HRP-conjugated
goat anti-mouse IgG Fc fragment and anti-mouse IgG
itsotype-specific antibodies (Bethyl Laboratory Inc., TX,
USA), respectively.
ELISA measurement of Igs and anti-DNA antibodies
The serum levels of total IgM, IgG, and autoantibodies
were measured by ELISA. For anti-ssDNA and -dsDNA
antibodies, high-bound flat-bottom 96-well plates were
coated firstly with 0.001% protamine sulfate in water for
60 min, and then with 5 μg/ml of single-strand or double-
strand calf thymus DNA (SIGMA) diluted in 0.015 M
sodium citrate containing 0.15 M NaCl for 90 min,
followed by blocking with 50% FCS in PBS for 60 min.
Serum samples were diluted to 1:100 with PBS containing
1% BSA and 0.05% Tween 20, and then applied to the
DNA-coated 96-well plates. Serum from a 12-month-old
NZB/W F1 female mouse was used as a control. After
washing three times with PBS containing 0.05% of Tween
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with HRP as detection antibodies. The total IgM and IgG
levels were measured with a Mouse IgM ELISA Quantita-
tion Set and a Mouse IgG ELISA Quantitation Set (Bethyl
Laboratory, Inc.), respectively, according to the manufac-
turer’s protocols. To titrate anti-DNA antibodies, a positive
control serum from an old female NZB/W F1 mouse was
examined for the anti-dsDNA and anti-ssDNA levels using
mouse monoclonal anti-dsDNA IgG2a (Abcam, Cambridge,
UK), which is also cross-reactive with ssDNA on
ELISA.
Flow cytometry
Spleens were isolated from B6 and RIIB−⁄− mice, and sus-
pended as single cells with PBS containing 1% BSA. Red
blood cells were depleted by lysis with 0.144 M NH4Cl.
2.0 × 106 cells per sample were blocked with 25 μg/ml anti-
FcγRII/III (2.4G2), incubated for 15 min at 4°C, and then
stained with fluorochrome-labeled antibodies. All fluores-
cent antibodies were used at 1:200 dilution. Data were
collected with FACSCalibur and FACSAria, and analyzed
using CellQuest and FACSDiva software (Becton Dickinson
Ltd.), respectively.
Statistical analysis
Statistical analysis was performed using Microsoft Excel
for Mac 2011 software version 14.2.3 (Microsoft Corp.,
Seattle, WA) or Prism6 software (Graph Pad Software
Inc., La Jolla, CA). Data are displayed when appropriate as
means ± SD. Data were compared for statistical differences
using Student’s t test with two-tailed analysis, Log-rank
test, or Chi-square test, as indicated in each figure legend.
P values are shown in the relevant figures. P <0.05 was
considered as statistically significant.
Results
RIIB−/−, SLAM129, and RIIB−/−SLAM129 lines with the B6
background thrive normally
RIIB−/− and SLAM129 mice were generated by backcross-
ing our 12th-backcross (N12) RIIB−/− mice [13,16] into
the B6 genetic background further to the 28th gener-
ation (N28). Analysis of a series of microsatellite markers
including D1Mit15, 36, and 113 in the vicinities of the
Fcgr2b and SLAM loci revealed the successful separation of
the RIIB−/− locus and the SLAM129 locus during the back-
cross (Figure 1A; for details, see Additional file 1: Figure S1
and Additional file 1: Table S1). We also obtained a mouse
line with the combined loci, N28 RIIB−/−SLAM129, as a
control (Figure 1A and Additional file 1: Figure S1). Both
the N28 RIIB−/− (RIIB−/−SENDAI) and N18 SLAM129 mice
thrived normally, at least up to 45 weeks after birth, and
the RIIB−/−SLAM129 mice did as well despite the fact that
female RIIB−/−SLAM129 mice manifested obvious glomer-
ulonephritis, as judged on histology (Figure 1B, see below),which was consistent with our previous observation for
N12 RIIB−/− mice [16]. Four (3 females and 1 male) out
of six (3 of each gender) RIIB−/− mice obtained from a
breeder (RIIB−⁄−TACONIC) died before 45 weeks of age
in our facility, due probably to lupus nephritis [21]
(Figure 1B). Mice obtained from another facility (RIIB−⁄
−TOKYO) [18] thrived like our RIIB−/− mice did. It
should be stressed that our RIIB−/−SENDAI line and
RIIB−/− animals from other sources were derived from a
common origin [13], and backcrossed into the B6 back-
ground at different facilities. These results indicate that,
even under identical environmental conditions,
FcγRIIB-deficient mice with 129-derived genetic inter-
vals of different lengths around the RIIB−/− locus show
different mortalities, raising the possibility of some in-
fluence(s) of unidentified genetic factor(s) within the
intervals in the B6 genetic background. Also, the separ-
ation of the RIIB−/− locus from that of autoimmune-
prone SLAM129 as well as extensive shortening of the
129-derived interval (Nuf2 to Fcgr4, Figure 1A) allowed
the establishment of N28 RIIB−/−SENDAI mice with a
normal survival rate, which we mainly used in our ana-
lysis described below.
RIIB−/− mice produce a small amount of ANAs
To gain an insight into the difference between RIIB−/− and
SLAM129 mice, and its relation to autoimmunity, we mea-
sured the total IgM and IgG levels in sera from these locus-
separated lines and the combined line, RIIB−/−SLAM129, as a
control, at the age of 24–28 weeks. We found that the IgM
levels in RIIB−/−SLAM129 mice but not RIIB−/− or SLAM129
mice were higher than that in B6 mice, while the IgG levels
were higher in female RIIB−/− mice and RIIB−/−SLAM129
mice of both genders, but not SLAM129 mice, than that
in B6 mice (Figure 2A). Regarding autoantibodies, both
RIIB−/− and SLAM129 mice at 36 weeks of age pro-
duced a detectable level of ANAs, but in much smaller
amounts than RIIB−/−SLAM129 mice did, as shown on
immunofluorescent staining of HEp-2 cells combined
with ELISA, and the levels were less than one-tenth to
that in a 12-month-old NZB/W F1 positive control mouse
(Figure 2B, upper). There was a tendency that the ANA
production and/or accumulation was more pronounced in
female than male RIIB−/− mice (P =0.067; Figure 2B,
upper), the female bias being more evident on the titration
with HEp-2-HEPANA Test at 24 weeks of age (P <0.0001;
Figure 2B, lower). This gender bias was not clear in
SLAM129 mice or a breeder’s RIIB−/− line (Figure 2B). We
also checked the IgG subclass of ANAs by HEp-2 ELISA
(Figure 2C), and found that IgG2c was the most promin-
ently produced subclass of ANAs in RIIB−/− mice, suggest-
ing that type 1 helper T cells are dominantly activated.
Examination of the staining profile of HEp-2 cells
(Figure 3A, B) indicated that ANAs detected in sera
AB
Figure 1 Chromosomal configurations in the vicinity of the Fcgr2b gene and SLAM locus of congenic mouse lines. (A) Physical mapping
was compiled according to the Ensemble Genome Browser (http://www.ensembl.org/). Upper, gross schematic view, and Lower, detailed genomic
structure with SSLP markers, and the genes related to the immune system and examined by SNP analysis (Additional file 1: Table S1 and Additional file 1:
Figure S1). Scale bar =1 Mbp. Thick horizontal bars below the map indicate 129 strain-derived intervals, and the flanking, thin broken lines denote
intervals unidentified for the B6 or 129 strain. Other areas not shown were derived from B6. The RIIB−⁄−TACONIC line had a 129-derived interval from
D1Mit34 to D1Mit150 at the minimum, while our N12 RIIB−⁄− had an interval from D1Mit102 to D1Mit221 at the minimum, according to our analysis. The
Fcr and SLAM loci are shown as shaded boxes at the top of the Upper panel or as thick lines above the map in the Lower panel. The Fcgr2b gene is boxed.
When pertinent, we refer to our N28 RIIB−/− mice used in the present study as RIIB−/−SENDAI and those obtained or purchased from others as RIIB−/−TOKYO
or RIIB−/−TACONIC, respectively, in order to distinguish the data in figures. (B) Survival curves for B6 (female, n =17), RIIB−/−SENDAI (female, n =30; male,
n =35), SLAM129 (female, n =23; male, n =27), RIIB−/−SLAM129 (female, n =14; male, n =18), RIIB−/−TOKYO (female, n =7; male, n =4), and RIIB−/−TACONIC
(female, n =3; male, n =3) mice. Mice of different lines were examined as to their survival until week 45. For comparison, survival curves for B6.lpr
(female, n =17) and RIIB−⁄−lpr (female, n =28; male, n =12) from our previous study [16] are superimposed. ****Significantly different between female
RIIB−/−TACONIC vs female RIIB−/−SENDAI (P <0.0001, Log-rank test).
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a mixture of anti-DNA, histone and nucleolus antibodies,
and others, because the staining could be classified into
nucleolar, homogeneous, and other types, while for the
ANAs at 28 and 36 weeks of age peripheral-type stain-
ing was dominant, indicating the anti-dsDNAantibodies were major (Figure 3C). When we compared
the staining profiles in female RIIB−/− and SLAM129
mice at 24 weeks of age, we observed that the
peripheral-type staining was dominant in SLAM129
mice (Figure 3C, lower), suggesting that the composi-
tions of ANAs produced by RIIB−/− and SLAM129 mice
AC
B
Figure 2 Female-biased production of anti-nuclear antibodies in RIIB−/− mice. (A) The total IgM and IgG levels in sera from different lines,
including B6, RIIB−/−, SLAM129, and RIIB−/−SLAM129, at 24–28 weeks of age of both genders were measured by ELISA. For IgM and IgG determinations in
male B6 mice, n =3 and 5, respectively; for other determinations, n ≥8. The data in each panel are from two separate measurements and are
presented as means ± S.D. *P <0.05; **P <0.01; ***P <0.001; ****P <0.0001; N.S., not significant. Student’s t-test. (B) Spontaneous production of ANAs by
SLAM129 (n =16), RIIB−/− (n =12), RIIB−/−SLAM129 (n =12), and B6 (n =6) mice at 36 weeks (Upper) or 24 weeks (Lower) of age of both genders was
measured in serum samples by HEp-2 staining combined with ELISA (Upper) and HEp-2-HEPANA Test (Lower), and expressed as the levels relative to
that in sera collected from a 12-month-old female NZB/W F1 mouse, whose anti-dsDNA and anti-ssDNA levels were 6.64 μg/ml and 4.69 μg/ml,
respectively. Horizontal lines represent the mean values. **P <0.01; ****P <0.0001; N.S., not significant. Student’s t-test. (C) IgG isotypes of ANAs in sera
from RIIB−/− and SLAM129 mice of both genders. ANA IgG isotypes were determined by HEp-2 staining combined with ELISA, and presented as values
relative to that in a 12-month-old NZB/W F1 control female mouse, as described in B.
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mined based on the HEp-2 cell staining profiles, albeit
the assay used is not sufficiently quantitative.
In addition to determination of the total ANA levels
described above, we also measured the anti-DNA levels in
sera from mice at different ages by ELISA. Anti-single-
stranded (ss)DNA and -double-stranded (ds)DNA anti-
bodies were detected, albeit in very small amounts, in
RIIB−/− mice at around 12 weeks and 16–20 weeks of age,respectively, and the levels were higher in females than
males after 28 weeks of age, while B6 female mice, as
healthy controls, at the same ages did not significantly
produce anti-DNA antibodies as compared to those in a
NZB/W F1 mouse as a disease control (Figure 4A). As
was the case for the serum ANA levels, RIIB−/−SLAM129
mice produced anti-DNA antibodies, particularly abun-
dantly in females (Figure 4B). The bias was not clear in a
breeder’s RIIB−/− line (Figure 4C, D). These results
BA
C
Figure 3 Qualitative analysis of ANAs in RIIB−⁄− and SLAM129 mice. (A) Classification of staining profiles of HEp-2 cells. Representative staining
patterns observed for serum samples from RIIB−⁄−SLAM129 mice are shown as fluorescently stained cells. (B) The classification of HEp-2 cell staining
pattern and the related antibodies and diseases. (C, Upper) Comparison of the HEp-2 staining patterns of female RIIB−/− mice at different ages.
The staining patterns were divided into six categories as shown in (B). (C, Lower) Comparison of the staining patterns between female RIIB−/− and
SLAM129 mice at 24 weeks of age. For classification, staining profiles in sera from ≥13 mice were evaluated. Ho, homogeneous; Pe, peripheral;
Cen, centromere; Sp, speckled; Nuc, nucleolar; etc, others. Significantly different between RIIB−/− and SLAM129 (P <0.0001 by Chi-square test).
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produce and/or maintain ANAs including anti-DNA
autoantibodies.
Weak glomerulonephritis in RIIB−/− mice
Given the production of anti-DNA antibodies by RIIB−/−
mice, we next examined the renal histology, and scored
the glomerulonephritis in male and female RIIB−/−,
SLAM129, and RIIB−/−SLAM129 mice at 36 weeks of age
(Figure 5). While control female RIIB−/−SLAM129 mice
exhibited severe glomerulonephritis with occasional
crescent formation, mesangial cell proliferation, macro-
phage and neutrophil infiltration, and lobulation of
glomeruli, female RIIB−/− mice exhibited weak but less
severe glomerulonephritis than control RIIB−/−SLAM129
animals, with mesangial cell proliferation and neutrophil
infiltration (Figure 5A, B). Male RIIB−/−, and male and
female SLAM129 mice only showed occasional mesangial
cell proliferation. We also examined IgG-IC deposition
in renal samples by immunofluorescence microscopy,
and found that only female RIIB−/− and RIIB−/−SLAM129
mice exhibited weak deposition (Figure 5C, D), butfemale SLAM129 mice did not (Figure 5C). These results
indicate that the development of glomerulonephritis
observed in RIIB−/− mice had occurred in a female-
biased manner, while SLAM129 mice did not develop
the disease at least until 36 weeks of age. It is note-
worthy that the development of glomerulonephritis
seemingly correlated with the female-biased ANA increase
in RIIB−/− and RIIB−/−SLAM129 animals described above
(Figure 4A–C), but SLAM129 mice did not manifest the
disease regardless of the fact that they produced ANAs at
comparable levels to female RIIB−/− mice, at least at
24 weeks of age (Figure 2B, C). This notion suggests a
contribution of FcγRIIB to protection from IgG-IC depos-
ition in glomeruli and glomerulonephritis.
Splenic germinal center formation was grossly normal in
RIIB−/− mice
We were interested in determining why ANAs and
anti-DNA antibodies in sera were increased in RIIB−/−
mice, albeit in very small amounts. To this end, we
isolated spleens, and examined their weights, hist-
ology, and cellularity. While splenomegaly was
A B
C D
Figure 4 Increase of anti-DNA antibodies in RIIB−/− mice. (A) Anti-ssDNA (upper) and -dsDNA (lower) antibody levels in sera from female and
male RIIB−/− mice, and female B6 mice at different ages. Anti-DNA levels were measured by ELISA and presented as values relative to that in a 12-
month-old NZB/W F1 control female mouse, whose anti-dsDNA and anti-ssDNA levels were 6.64 μg/ml and 4.69 μg/ml, respectively. Each data point
represents the mean value ± SD (n ≥3). Significantly different between female RIIB−/− and B6 (*P <0.05) with Student’s t-test. (B–D) Anti-DNA antibody
(B, D) levels and ANA levels (C) in sera from female and male RIIB−⁄−SENDAI or TACONIC mice, RIIB−⁄−SLAM129, and B6 mice at different ages. Anti-DNA
levels and ANAs were measured by ELISA and HEp-2 staining combined with ELISA, respectively, and presented as values relative to that in a
12-month-old NZB/W F1 control female mouse as described in A. Each data point represents the mean value ± SD (n ≥3). *P <0.05. Student’s
t-test. In B, the plots for RIIB−⁄− and B6 mice in A were superimposed for comparison. In D, the plots for RIIB−⁄−SLAM129 and B6 mice in B and
A, respectively, were superimposed for comparison.





Figure 5 Glomerulonephritis in RIIB−/−, SLAM129, and RIIB−/−SLAM129 mice. (A) Kidney sections from each mouse line at week 45 were stained
with HE (upper) and PAS (lower) for examination of glomerular disease, which was assessed according to the criteria depicted in Methods. Original
magnification, ×200. Scale bar, 100 μm. (B) Comparison of the disease scores among RIIB−/−, SLAM129, RIIB−/−SLAM129 and B6 mice at 45 weeks of age.
F, female; M, male. Horizontal bars denote the mean values, excepting the plot of RIIB−⁄−SLAM129 male for single determination. ***P <0.001 (n =3–6).
For scoring, ≥25 glomeruli were examined for each line. Student’s t-test. (C, D) For IgG-immune complexes (IgG-ICs) deposition, kidney sections from
each mouse line at week 45 were stained with FITC-anti mouse IgG. Original magnification, ×200 (C) or × 100 (D). Scale bar, 10 μm. The figure is
representative of most of the glomeruli observed in three mice per group.
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http://www.biomedcentral.com/1471-2172/15/47observed in RIIB−/−SLAM129 mice, it was much less
evident in RIIB−/− mice (Figure 6A, left). This was, how-
ever, not pronounced in the total splenic lymphocytes ofRIIB−/− animals (Figure 6A, right). Immunohistochemistry
of spleen sections prepared from naïve mice indicated
that germinal center (GC) formation was grossly
Kanari et al. BMC Immunology 2014, 15:47 Page 10 of 13
http://www.biomedcentral.com/1471-2172/15/47normal in RIIB−/− mice of both genders, while it was
augmented in SLAM129 mice (Figure 6B). The numbers
of total GL7+Fas+ GC cells and CD19+GL7+Fas+ GC B
cells were not significantly increased in RIIB−/− mice of
both genders, while they tended to be increased in
female RIIB−/−SLAM129 and SLAM129 animals (Figure 6C,
D), these observations being reminiscent of SLAM’s
important role in adequate B–T cell communication in
GCs [22]. Thus, we failed to find marked alterations in
RIIB−/− mice in terms of the total splenic lymphocyte
and GC cell numbers other than slight splenomegaly.
Further analysis of other parameters such as plasma
cells, antigen-presenting cells and T cells may help to
clarify the reason for the production of a small amount
of autoantibodies in RIIB−/− mice.
Discussion
The exact effect of RIIB deficiency on spontaneous
development of autoimmune diseases is controversial.
Regarding animal models, RIIB gene-targeted mice de-
rived from ES cells of the 129 strain and backcrossed into
the B6 genetic background yielded different phenotypes in
different laboratories, most probably due to different con-
tributions of the autoimmune-prone SLAM129 haplotype
neighboring the RIIB locus [4,5,23,24]. In this study, we,
for the first time, established two lines through extensive
backcrossing, one line with RIIB deficiency but the non-
autoimmune B6 SLAM haplotype, and the other with
autoimmune-prone SLAM129 and the intact RIIB gene,
both having the B6 background and being housed under
identical environmental conditions. We found that the
RIIB deficiency indeed caused a spontaneous increase of a
very small amount of ANAs including anti-DNA autoanti-
bodies, and weak glomerulonephritis with slight IgG-IC
deposition in glomeruli in a female-biased manner, while
the SLAM129 line exhibited ANA production accompany-
ing no obvious glomerulonephritis, IgG-IC deposition
being minimum and comparable to that in the B6 control.
RIIB is known to be an important suppressor of the pro-
duction and/or accumulation of autoantibodies in some
animal models, in which the diseases were induced experi-
mentally in autoimmune-prone mouse strains or non-
autoimmune B6 mice by immunization [15,16,25-28]. A
recent report [19] has pointed out the additional role of
RIIB, expressed in liver sinusoidal endothelial cells, in the
clearance of small size IgG-ICs, and potentially in minimiz-
ing the level of pathologic IgG-ICs in the blood. In contrast
to well-established feedback immunoregulation, and its cru-
cial role in suppressing autoantibody production and/or ac-
cumulation after active immunization of susceptible mice,
the role of RIIB in physiological suppression of spon-
taneous autoantibody production in non-autoimmune
strains remained unclear due to the inconsistent pheno-
types of RIIB-deficient mice observed in differentlaboratories [8,16-18], the mice being extremely prone to
the production of anti-chromatin autoantibodies and sus-
ceptible to the development of fatal lupus [8,21], whereas
in others they were not susceptible to the development of
lupus nephritis without massive production of autoanti-
bodies [16-18]. To circumvent the difficulty in isolating the
effect of RIIB deficiency by backcrossing, Boross et al. gen-
erated B6- but not 129-origin RIIB-deficient mice by gene
targeting in B6-derived ES cells [17]. They observed that
RIIB-deficient mice produced only a small amount of
anti-ssDNA antibodies spontaneously even at the age of
10 months, exhibited slight IgG-IC deposition in the
kidneys, and increases in urinary albumin and the patho-
logical score of glomerulonephritis, without showing mor-
tality at least up to 12 months of age, indicating that RIIB
deficiency only amplifies spontaneous autoimmunity deter-
mined by other loci. These phenotypes are mostly the same
as those of our RIIB−/− mice in this study in terms of the
very low ANA level and slight IgG-IC deposition without
development of glomerulonephritis. Similar results have
also been obtained for congenic lines within the Nba2
autoimmune susceptibility locus [29]. Thus, our present
observations substantially support those reported for B6-
based RIIB−/− mice [17], and our results also indicate that
RIIB prevents the spontaneous production and/or accumu-
lation of a small amount of ANAs.
The IgG-IC deposition, albeit slight, and the increase in
the pathological score for glomerulonephritis in RIIB−/−
mice were unexpected, because these phenotypes were not
observed in the SLAM129 line housed under the same
environmental conditions as RIIB−/− mice (Figure 5). These
observations are also consistent with those for the B6-
based RIIB-deficient mice [17]. Interestingly, a recent study
employing a cell type-specific RIIB deletion technique has
shown that RIIB on myeloid cells and intrinsic renal cells
rather than B cells prevents nephrotoxic nephritis, suggest-
ing a significant role of RIIB on myeloid cells and renal
mesangial cells in this protection [30]. It has also been
shown that neither B cell- nor myeloid-specific deletion of
RIIB leads to the development of crescentic glomerulo-
nephritis with a higher incidence than in wild-type mice in
an anti-glomerular basement membrane antibody disease
model, indicating that RIIB deficiency in either B cells or a
subset of myeloid cells alone is not sufficient to increase
the susceptibility to the kidney disease [31]. In contrast to
RIIB−/− mice, SLAM129 animals did not show IgG-IC
deposition in the kidneys, even though they had a compar-
able level of serum ANAs to that in RIIB−/− mice, at least at
24 weeks of age. Thus, the SLAM129 haplotype in the B6
background does not contribute to the development of
glomerulonephritis but to ANA production, due to the lack
of a significant role in the kidneys.
Generally, development of autoimmune diseases is




Figure 6 Germinal center B cells are increased in SLAM129 but not RIIB−/− mice. (A, Left) Slight splenomegaly in female RIIB−/− mice. Spleen
weights were measured for each line of both genders (F, female; M, male) and are presented as the ratio of the weight per body weight.
Horizontal bars indicate mean values, excepting the plot of RIIB−⁄−SLAM129 male for single determination. ***P <0.001. Student’s t-test. (A, Right)
Total splenic lymphocytes in each line. Horizontal bar represents the mean number of total splenocytes, excepting the plot of RIIB−⁄−SLAM129
male for single determination. N.S., not significant. Student’s t-test. (B) Germinal center formation in naïve B6, N22 female RIIB−/−, and female and
male SLAM129 mice at 45 weeks of age. Frozen spleen sections were stained with GL7-Alexa488 and Alexa546-labeled anti-mouse IgD antibodies.
Scale bar =10 μm. (C) Flow cytometric determination of germinal center (GC) B cells of B6, female SLAM129 and N22 female RIIB−/− mice at
45 week of age. Splenocytes were gated with anti-CD19-APC, and analyzed for anti-Fas-PE and GL7-FITC. (D) Total GC cells and GC B cells are not
significantly increased in female RIIB−/− mice. The percentage of GC B cells in splenic CD19+ cells (Left), and the absolute number of splenic GC B
cells (Right) of each line of both genders (F, female; M, male) are shown. *P <0.05; ***P <0.001; N.S., not significant. Student’s t-test.
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hormones on the immune system and cells [32-34]. The
reason for the gender bias in the ANA levels in RIIB−⁄−
mice rather than SLAM129 mice is currently unknown,
although one may speculate that antigen-presenting
cell–T cell communication could be more prone to be
de-regulated in females than B cell–T cell interactions,
which could be influenced by SLAM129. Further examina-
tions will clarify the differences in gender in splenocytes
and lymph node cells, and even in those in the lamina
propria.
Conclusion
Separation of the RIIB−/− locus from the autoimmune-
prone SLAM129 locus revealed the role of RIIB in main-
tenance of peripheral tolerance. As judged on assessment
under identical genetic and environmental conditions,
RIIB deficiency caused slight ANA production and/or its
accumulation accompanied by non-lethal glomeruloneph-
ritis with a low level of IgG-IC deposition, in contrast to
the role of SLAM129, which causes ANA production with-
out accompanying glomerulonephritis. The combination
of the RIIB deficiency and SLAM129 synergistically in-
duced substantial ANA production and sub-lethal glomer-
ulonephritis. These results will facilitate development of
strategies for targeting RIIB for treating autoimmune
disorders involving autoantibody production such as SLE.
Additional file
Additional file 1: Tables S1 and S2 and Figures S1 and S2.
Abbreviations
ANA: Anti-nuclear antibody; B6: C57BL/6; ds-: Double-stranded; FcγRIIB: Type
IIB low affinity Fc receptor for IgG; FcR: Fc receptor; FcγR: Fc receptor for IgG;
GC: Germinal center; HE: Hematoxylin and eosin; RIIB: FcγRIIB; RIIB−⁄−: FcγRIIB-
deficient; RIIB−⁄−SENDAI mice: N28 FcγRIIB-deficient mice; ss-: Single-stranded;
SLAM: Signal lymphocyte activation molecule(s); SLE: Systemic lupus
erythematosus.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YK participated in the design of the study and with HT carried out the
analysis of mice and performed the statistical analysis. AST carried out the
backcross, genetic analysis, and maintenance of mice, and histological
examinations. MI and AN participated in the design of the study. SH
provided the mice and participated in the design of the study. TT conceived
of the study with AN, and participated in its design and coordination and
drafted the manuscript. All authors read and approved the final manuscript.
Acknowledgements
We thank Masato Nose (Tohoku Univ. Graduate School of Medicine) for the
pathological analysis and Nicholas Halewood for the editorial assistance. This
work was supported by the Core Research for Evolutional Science and
Technology Program of the Japan Science and Technology Agency, a Grant-in-
Aid from the Ministry of Education, Culture, Sports, Science and Technology of
Japan, and a grant from the Global Center of Excellence Program for Innovative
Therapeutic Development Towards the Conquest of Signal Transduction
Diseases with Network Medicine.Author details
1Department of Experimental Immunology and CREST Program of JST,
Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo,
Sendai 980-8575, Japan. 2Department of Immunology, Kanazawa Medical
University, Kanazawa, Ishikawa 920-0293, Japan. 3Department of Pathology,
Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo
113-8421, Japan.
Received: 28 June 2014 Accepted: 9 October 2014References
1. Wakeland EK, Liu K, Graham RR, Behrens TW: Delineating the genetic basis
of systemic lupus erythematosus. Immunity 2001, 15:397–408.
2. Wang A, Batteux F, Wakeland EK: The role of SLAM/CD2 polymorphisms in
systemic autoimmunity. Curr Opin Immunol 2010, 22:706–714.
3. Wandstrat A, Wakeland E: The genetics of complex autoimmune diseases:
non-MHC susceptibility genes. Nat Immunol 2001, 2:802–809.
4. Wandstrat AE, Nguyen C, Limaye N, Chan AY, Subramanian S, Tian XH, Yim
YS, Pertsemlidis A, Garner HR Jr, Morel L, Wakeland EK: Association of
extensive polymorphisms in the SLAM/CD2 gene cluster with murine
lupus. Immunity 2004, 21:769–780.
5. Bygrave AE, Rose KL, Cortes-Hernandez J, Warren J, Rigby RJ, Cook HT,
Walport MJ, Vyse TJ, Botto M: Spontaneous autoimmunity in 129 and
C57BL/6 mice—Implications for autoimmunity described in gene-
targeted mice. PLoS Biol 2004, 2:e243.
6. Kumar KR, Li L, Yan M, Bhaskarabhatla M, Mobley AB, Nguyen C, Mooney
JM, Schatzle JD, Wakeland EK, Mohan C: Regulation of B cell tolerance by
the lupus susceptibility gene Ly108. Science 2006, 312:1665–1669.
7. Daëron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH:
The same tyrosine-based inhibition motif, in the intracytoplasmic
domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent
cell activation. Immunity 1995, 3:635–646.
8. Bolland S, Ravetch JV: Spontaneous autoimmune disease in FcγRIIB-deficient
mice results from strain-specific epistasis. Immunity 2000, 13:277–285.
9. Ravetch JV, Bolland S: IgG Fc receptors. Annu Rev Immunol 2001,
19:275–290.
10. Nimmerjahn F, Ravetch JV: Fcγ receptors as regulators of immune
responses. Nat Rev Immunol 2008, 8:34–47.
11. Takai T: Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002,
2:580–592.
12. Smith KGC, Clatworthy MR: FcγRIIB in autoimmunity and infection:
evolutionary and therapeutic implications. Nat Rev Immunol 2010,
10:328–343.
13. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV: Augmented humoral and
anaphylactic responses in FcγRII-deficient mice. Nature 1996,
379:346–349.
14. Suzuki Y, Shirato I, Okumura K, Ravetch JV, Takai T, Tomino T, Ra C: Distinct
contribution of Fc receptors and angiotensin II-dependent pathways in
anti-GBM glomerulonephritis. Kidney Int 1998, 54:1166–1174.
15. Clynes R, Maizes JS, Guinamard R, Ono M, Takai T, Ravetch JV: Modulation
of immune complex-induced inflammation in vivo by the coordinate
expression of activation and inhibitory Fc receptors. J Exp Med 1999,
189:179–185.
16. Yajima K, Nakamura A, Sugahara A, Takai T: FcγRIIB deficiency with Fas
mutation is sufficient for the development of systemic autoimmune
disease. Eur J Immunol 2003, 33:1020–1029.
17. Boross P, Arandhara VL, Martin-Ramirez J, Santiago-Raber ML, Carlucci F,
Flierman R, van der Kaa J, Breukel C, Claassens JW, Camps M, Lubberts E,
Salvatori D, Rastaldi MP, Ossendorp F, Daha MR, Cook HT, Izui S, Botto M,
Verbeek JS: The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of
autoimmune susceptibility. J Immunol 2011, 187:1304–1313.
18. Sato-Hayashizaki A, Ohtsuji M, Lin Q, Hou R, Ohtsuji N, Nishikawa K, Tsurui H,
Sudo K, Ono M, Izui S, Shirai T, Takai T, Nishimura H, Hirose S: Presumptive
role of 129 strain-derived Sle16 locus in rheumatoid arthritis in a new
mouse model with Fcγ receptor type IIb-deficient C57BL/6 genetic
background. Arthritis Rheum 2011, 63:2930–2938.
19. Ganesan LP, Kim J, Wu Y, Mohanty S, Phillips GS, Birmingham DJ, Robinson
JM, Anderson CL: FcγRIIb on liver sinusoidal endothelium clears small
immune complexes. J Immunol 2012, 189:4981–4988.
Kanari et al. BMC Immunology 2014, 15:47 Page 13 of 13
http://www.biomedcentral.com/1471-2172/15/4720. Shi X, Xie C, Kreska D, Richardson JA, Mohan C: Genetic dissection of SLE:
SLE1 and FAS impact alternate path- ways leading to lymphoproliferative
autoimmunity. J Exp Med 2002, 196:281–292.
21. Pisitkun P, Ha HL, Wang H, Claudio E, Tivy CC, Zhou H, Mayadas TN, Illei GG,
Siebenlist U: Interleukin-17 cytokines are critical in development of fatal
lupus glomerulonephritis. Immunity 2012, 37:1104–1115.
22. Cannons JL, Qi H, Lu KT, Dutta M, Gomez-Rodriguez J, Cheng J, Wakeland
EK, Germain RN, Schwartzberg PL: Optimal germinal center responses
require a multistage T cell:B cell adhesion process involving integrins,
SLAM-associated protein, and CD84. Immunity 2010, 32:253–265.
23. Heidari Y, Bygrave AE, Rigby RJ, Rose KL, Walport MJ, Cook HT, Vyse TJ,
Botto M: Identification of chromosome intervals from 129 and C57BL/6
mouse strains linked to the development of systemic lupus
erythematosus. Genes Immun 2006, 7:592–599.
24. Carlucci F, Cortes-Hernandez J, Fossati-Jimack L, Bygrave AE, Walport MJ, Vyse
TJ, Cook HT, Botto M: Genetic dissection of spontaneous autoimmunity
driven by 129-derived chromosome 1 Loci when expressed on C57BL/6
mice. J Immunol 2007, 178:2352–2360.
25. Nakamura A, Nukiwa T, Takai T: Deregulation of peripheral B-cell
development in enhanced severity of collagen-induced arthritis in
FcγRIIB-deficient mice. J Autoimmun 2003, 20:227–236.
26. Kleinau S, Martinsson P, Heyman B: Induction and suppression of
collagen-induced arthritis is dependent on distinct Fcγ receptors.
J Exp Med 2000, 191:1611–1616.
27. Yuasa T, Kubo S, Yoshino T, Ujike A, Matsumura K, Ono M, Ravetch JV, Takai
T: Deletion of FcγRIIB renders H-2b mice susceptible to collagen-induced
arthritis. J Exp Med 1999, 189:187–194.
28. Nakamura A, Yuasa T, Ujike A, Ono M, Nukiwa T, Ravetch JV, Takai T: Fcγ
receptor IIB-deficient mice develop Goodpasture’s syndrome upon
immunization with type IV collagen: a novel murine model for
autoimmune glomerular basement membrane disease. J Exp Med 2000,
191:899–906.
29. Jørgensen TN, Alfaro J, Enriquez HL, Jiang C, Loo WM, Atencio S, Bupp MR,
Mailloux CM, Metzger T, Flannery S, Rozzo SJ, Kotzin BL, Rosemblatt M,
Bono MR, Erickson LD: Development of murine lupus involves the
combined genetic contribution of the SLAM and FcγR intervals within
the Nba2 autoimmune susceptibility locus. J Immunol 2010, 184:775–786.
30. Sharp PE, Martin-Ramirez J, Mangsbo SM, Boross P, Pusey CD, Touw IP, Cook
HT, Verbeek JS, Tarzi RM: FcγRIIb on myeloid cells and intrinsic renal cells
rather than B cells protects from nephrotoxic nephritis. J Immunol 2013,
190:340–348.
31. Sharp PE, Martin-Ramirez J, Boross P, Mangsbo SM, Reynolds J, Moss J, Pusey
CD, Cook HT, Tarzi RM, Verbeek JS: Increased incidence of anti-GBM
disease in Fcgamma receptor 2b deficient mice, but not mice with
conditional deletion of Fcgr2b on either B cells or myeloid cells alone.
Mol Immunol 2012, 50(1–2):49–56.
32. Rubtsov AV, Rubtsova K, Kappler JW, Marrack P: Genetic and hormonal
factors in female-biased autoimmunity. Autoimmun Rev 2010, 9:494–498.
33. González DA, Díaz BB, Rodríguez Pérez Mdel C, Hernández AG, Chico BN, de
León AC: Sex hormones and autoimmunity. Immunol Lett 2010, 133:6–13.
34. Talal N: Mechanisms of autoimmunity in systemic lupus erythematosus.
Clin Immunol Newslett 1981, 2:103–106.
doi:10.1186/s12865-014-0047-y
Cite this article as: Kanari et al.: Dichotomy in FcγRIIB deficiency and
autoimmune-prone SLAM haplotype clarifies the roles of the Fc
receptor in development of autoantibodies and glomerulonephritis.
BMC Immunology 2014 15:47.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
